Yovine A - Search Results

1

A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.

Zelek L, Yovine A, Brain E, Turpin F, Taamma A, Riofrio M, Spielmann M, Jimeno J, Misset JL. Zelek L, et al. Among authors: yovine a. Br J Cancer. 2006 Jun 5;94(11):1610-4. doi: 10.1038/sj.bjc.6603142. Br J Cancer. 2006. PMID: 16736024 Free PMC article. Clinical Trial.

2

Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.

Gornet JM, Azoulay D, Lévi F, Yovine A, Misset JL, Goldwasser F. Gornet JM, et al. Among authors: yovine a. Anticancer Drugs. 2000 Apr;11(4):263-8. doi: 10.1097/00001813-200004000-00006. Anticancer Drugs. 2000. PMID: 10898541

3

Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.

Goldwasser F, Gross-Goupil M, Tigaud JM, Di Palma M, Marceau-Suissa J, Wasserman E, Yovine A, Misset JL, Cvitkovic E. Goldwasser F, et al. Among authors: yovine a. Ann Oncol. 2000 Nov;11(11):1463-70. doi: 10.1023/a:1026535824044. Ann Oncol. 2000. PMID: 11142487 Free article. Clinical Trial.

4

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Delaloge S, Yovine A, Taamma A, Riofrio M, Brain E, Raymond E, Cottu P, Goldwasser F, Jimeno J, Misset JL, Marty M, Cvitkovic E. Delaloge S, et al. Among authors: yovine a. J Clin Oncol. 2001 Mar 1;19(5):1248-55. doi: 10.1200/JCO.2001.19.5.1248. J Clin Oncol. 2001. PMID: 11230465 Clinical Trial.

5

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Yovine A, Riofrio M, Blay JY, Brain E, Alexandre J, Kahatt C, Taamma A, Jimeno J, Martin C, Salhi Y, Cvitkovic E, Misset JL. Yovine A, et al. J Clin Oncol. 2004 Mar 1;22(5):890-9. doi: 10.1200/JCO.2004.05.210. J Clin Oncol. 2004. PMID: 14990645 Clinical Trial.

6

Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patients.

Alexandre J, Raymond E, Kaci MO, Brain EC, Lokiec F, Kahatt C, Faivre S, Yovine A, Goldwasser F, Smith SL, MacDonald JR, Misset JL, Cvitkovic E. Alexandre J, et al. Among authors: yovine a. Clin Cancer Res. 2004 May 15;10(10):3377-85. doi: 10.1158/1078-0432.CCR-03-0349. Clin Cancer Res. 2004. PMID: 15161692 Clinical Trial.

7

Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.

Petit T, Benider A, Yovine A, Bougnoux P, Spaeth D, Maindrault-Goebel F, Serin D, Tigaud JD, Eymard JC, Simon H, Bertaux B, Brienza S, Cvitkovic E. Petit T, et al. Among authors: yovine a. Anticancer Drugs. 2006 Mar;17(3):337-43. doi: 10.1097/00001813-200603000-00013. Anticancer Drugs. 2006. PMID: 16520663 Clinical Trial.

8

A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.

Delozier T, Guastalla JP, Yovine A, Levy C, Chollet P, Mousseau M, Delva R, Coeffic D, Vannetzel JM, Zazzi ES, Brienza S, Cvitkovic E. Delozier T, et al. Among authors: yovine a. Anticancer Drugs. 2006 Oct;17(9):1067-73. doi: 10.1097/01.cad.0000231475.77159.aa. Anticancer Drugs. 2006. PMID: 17001180 Clinical Trial.

9

QTc monitoring during a phase I study: experience with SR271425.

Soria JC, Dieras V, Girre V, Yovine A, Mialaret K, Armand JP. Soria JC, et al. Among authors: yovine a. Am J Clin Oncol. 2007 Apr;30(2):106-12. doi: 10.1097/01.coc.0000255604.32888.b5. Am J Clin Oncol. 2007. PMID: 17414458 Clinical Trial.

10

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials.

Le Cesne A, Yovine A, Blay JY, Delaloge S, Maki RG, Misset JL, Frontelo P, Nieto A, Jiao JJ, Demetri GD. Le Cesne A, et al. Among authors: yovine a. Invest New Drugs. 2012 Jun;30(3):1193-202. doi: 10.1007/s10637-011-9662-0. Epub 2011 Apr 12. Invest New Drugs. 2012. PMID: 21484250 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters